Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Alcorcón
Clinical trial register · Spain

Clinical Trials in Alcorcón, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Universidad Rey Juan Carlos5 AbbVie5 Hoffmann-La Roche4 Incyte Corporation3 AstraZeneca3
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Alcorcón

61 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Carolina Ortiz Cortes
Observational
430
Santiago de Compostela, Donostia / San Sebastian, Úbeda, Las Palmas de Gran Canaria, Alcorcón, Boadilla del Monte, Leganés, Majadahonda
2026-09-17
Recruiting
Rovi Pharmaceuticals Laboratories
Phase 1
120
Alcorcón, Barcelona, Granada, Jaén, León, Lleida, Manresa, Málaga
2026-06-08
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Sant Joan Despí, Valencia, A Coruña, Alcorcón, Antequera, Badalona, Barcelona, Bilbao
2026-05-11
Recruiting
Hoffmann-La Roche
Phase 3
900
Elche, Sant Cugat del Vallès, Donostia / San Sebastian, A Coruña, Alcorcón, Pozuelo de Alarcón, Barcelona, Madrid
2025-11-24
Recruiting
Incyte Corporation
Phase 3
250
Alcorcón, Badalona, Barcelona, Esplugues de Llobregat, Madrid, Zaragoza
2025-11-13
Recruiting
Pfizer
Phase 2
200
Santiago de Compostela, Córdoba, Barcelona, Alcorcón, Valencia
2025-10-30
By invitation
Universidad Rey Juan Carlos
Not applicable
67
Alcorcón
2025-10-27
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Badalona, Barcelona, Las Palmas de Gran Canaria, Alcorcón, Málaga, Salamanca, Seville, Madrid
2025-09-22
Not yet open
Effectiveness of Immersive Virtual Reality Combined With Occupational Therapy in Reducing Fall Risk and Frailty Among Older Adults
NCT07060677Frailty Syndrome, Older Adults, Balance, Fall Prevention in Healthy Aging
Universidad Rey Juan Carlos
Not applicable
30
Alcorcón, Madrid
2025-09-15
Recruiting
Universidad Rey Juan Carlos
Not applicable
64
Alcorcón
2025-09-08
Recruiting
AstraZeneca
Phase 2
55
A Coruña, Alcorcón, Badalona, Barcelona, Burgos, Donostia / San Sebastian, Gijón, Madrid
2025-09-05
Recruiting
AbbVie
Observational
2,795
Jaén, Alcorcón, Majadahonda, Parla, San Cristóbal de La Laguna, Valencia
2025-09-02
Recruiting
Neurocrine Biosciences
Phase 3
550
Alcorcón, Barcelona
2025-08-18
Recruiting
Takeda
Phase 3
150
Alcorcón, Madrid, Burgos, Salamanca, Seville
2025-08-14
Active, closed
AbbVie
Phase 3
573
Santiago de Compostela, Granollers, Manresa, Las Palmas de Gran Canaria, Alcorcón, Majadahonda, Gijón, Seville
2025-06-17
Recruiting
Hoffmann-La Roche
Phase 3
425
Alcorcón, Majadahonda, Madrid, Zaragoza
2025-05-12
Recruiting
Biogen
Phase 3
454
Viladecans, Barcelona, A Coruña, Alcorcón, Getafe, Cáceres, Girona, Madrid
2025-05-08
Recruiting
AstraZeneca
Phase 3
400
Alcorcón, Alzira (Valencia), Badalona, Barakaldo, Barcelona, Burgos, Cáceres, Granada
2025-03-28
Active, closed
MarsiBionics
Not applicable
15
Alcorcón, Madrid
2025-03-01
Recruiting
Incyte Corporation
Phase 3
600
Alcorcón, Alicante, Badalona, Barcelona, Córdoba, Granada, Las Palmas de Gran Canaria, Madrid
2025-02-28
Recruiting
Takeda
Phase 3
171
Alcorcón, Madrid, Salamanca, Seville
2025-02-27
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Alcorcón, Barcelona, Castilleja de la Cuesta, Dénia, Madrid, Malag, Málaga, Salt
2025-01-13
Recruiting
Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.
NCT06790368Allergy, Insect Venom, Allergy Insect Stinging, Insect Sting Allergy
DrugVenox
Inmunotek S.L.
Observational
80
Alcorcón, Córdoba, Guadalajara
2025-01-01
Active, closed
PPM Services S.A.
Phase 3
400
Alcorcón, Barcelona, Esplugues de Llobregat, Granada, Madrid, Málaga, Seville, Valencia
2024-12-05
Recruiting
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 3
94
Alcorcón, Leganés, Albacete, Burgos, Córdoba, Valencia
2024-10-03
Recruiting
Ferring Pharmaceuticals
Phase 3
250
Santander, Barcelona, Córdoba, A Coruña, Alcorcón, Madrid, Pamplona, Bilbao
2024-10-01
Recruiting
Ferring Pharmaceuticals
Phase 3
454
Santander, Barcelona, Córdoba, A Coruña, Granada, Alcorcón, Madrid, Bilbao
2024-10-01
By invitation
Universidad Rey Juan Carlos
Not applicable
100
Alcorcón
2024-09-24
Active, closed
AstraZeneca
Phase 2
194
A Coruña, Alcorcón, Barcelona, Madrid, Málaga, Pamplona, Santander, Santiago de Compostela
2024-08-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Málaga, Centelles, Barcelona, Figueres, A Coruña, Santiago de Compostela, Pozuelo de Alarcón, Alcorcón
2024-08-05
Active, closed
GlaxoSmithKline
Phase 3
10,212
Santiago de Compostela, Centelles, Vic, Majadahonda, Alcorcón, Barcelona, Madrid, Valencia
2024-08-01
Recruiting
Effectiveness of Pulpotomy in Symptomatic Permanent Teeth With Deep Caries Lesions
NCT06918639Irreversible Pulpitis, Pulpotomy of Permanent Molars
Universidad Rey Juan Carlos
Observational
50
Alcorcón
2024-04-11
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Alcorcón, Badalona, Barcelona, Manises, Salamanca, Santiago de Compostela, Seville, Villajoyosa
2024-03-09
Active, closed
Eli Lilly and Company
Phase 3
17,300
A Coruña, Alcorcón, Badalona, Barcelona, Córdoba, Denia, El Palmar, Murcia, Ferrol
2024-03-05
Recruiting
OrigenKinesis fisioterapia
Not applicable
40
Alcorcón
2024-02-17
Active, closed
Incyte Corporation
Phase 3
467
Alcorcón, Badalona, Barcelona, Madrid, Manises
2023-11-29
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Alcorcón, Alicante, Barcelona, Bilbao, Madrid, Palma de Mallorca, Santiago de Compostela, Seville
2023-10-12
Recruiting
Gilead Sciences
Phase 3
402
A Coruña, Alcorcón, Badalona, Barcelona, Córdoba, Málaga, Santander, Seville
2023-09-07
Recruiting
Quality of Life and Psychological Strengths of Older People
NCT06381037Quality of Life, Skills, Coping
CEU San Pablo University
Not applicable
110
Alcorcón
2023-09-01
Active, closed
Janssen Research & Development, LLC
Phase 3
213
Alcorcón, Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Pamplona, Pozuelo de Alarcón
2022-12-15
Active, closed
Biogen
Phase 2/3
450
Badalona, Valladolid, Castellon, Alcorcón, Majadahonda, A Coruña, Barcelona, Córdoba
2022-09-13
Recruiting
AbbVie
Phase 3
768
Las Palmas de Gran Canaria, Alcorcón, Fuenlabrada, Ávila, Barcelona, Jaén, Madrid, Valencia
2022-03-25
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Cadiz, Seville, Barcelona, Sant Joan Despí, Salt, Alcorcón, Getafe, Majadahonda
2021-12-16
Active, closed
AbbVie
Phase 1
520
Santiago de Compostela, Badalona, Alcorcón, Pamplona, Barcelona, Jaén, Madrid, Seville
2021-10-13
Recruiting
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
NCT04898283Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
Drugs10,000 MG01·30,000 MG01
Inmunotek S.L.
Phase 3
180
Valladolid, Tarancón, Alcalá de Henares, Alcorcón, Madrid, Majadahonda, Murcia, Ávila
2021-05-31
Active, closed
Hoffmann-La Roche
Phase 2
586
Elche, Sant Cugat del Vallès, Donosti-San Sebastián, A Coruña, Alcorcón, Móstoles, Pozuelo de Alarcón, Pamplona
2021-05-05
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Albacete, Alcorcón, Alcoy, Alicante, Almería, Asturias, Badajoz, Barakaldo
2021-01-15
Active, closed
Daiichi Sankyo
Phase 3
1,600
Bilbao, El Palmar, Reus, A Coruña, Alcorcón, Alicante, Badajoz, Barcelona
2020-12-04
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
DrugsXeloda·Sacituzumab Govitecan·Paraplatin·Capecitabine
GBG Forschungs GmbH
Phase 3
1,332
Barakaldo, A Coruña, Albacete, Alcorcón, Alcoy, Alicante, Badalona, Barcelona
2020-10-28
Active, closed
Bayer
Phase 3
402
Elche, Manacor, Palma de Mallorca, Sabadell, Alcorcón, Barcelona, Cáceres, Córdoba
2020-10-20
Active, closed
Exelixis
Phase 3
575
Elche, Palma de Mallorca, Manresa, Santiago de Compostela, Alcorcón, Oviedo, Badalona, Barcelona
2020-10-19
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Barcelona, Alcorcón, Torrejón de Ardoz, Badalona, Madrid, Majadahonda, Salamanca, Seville
2019-06-04
Active, closed
AbbVie
Phase 2
270
Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Alcorcón, Ávila, Barcelona, Madrid, Málaga
2018-10-10
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Folinic acid·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Badalona, Ávila, Alcorcón, Barcelona, Burgos, Madrid, Murcia, Seville
2018-06-21
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Alcorcón, Barcelona, Bilbao, Cartagena, Córdoba, Las Palmas de Gran Canaria, Pamplona, Sabadell
2017-09-25
Active, closed
Eli Lilly and Company
Phase 3
5,637
Córdoba, Barcelona, Santiago de Compostela, Lleida, Pozuelo de Alarcón, Alcorcón, Madrid, Málaga
2017-07-12
Active, closed
Hoffmann-La Roche
Phase 2
316
Sant Cugat del Vallès, Donostia / San Sebastian, Alcorcón, Pamplona/iruña, Barcelona, Madrid, Seville
2017-06-27
Recruiting
Spanish Breast Cancer Research Group
Observational
1,867
Elche, Manresa, Terrassa, San Sebastián, Las Palmas de Gran Canaria, Alcorcón, Fuenlabrada, Leganés
2016-08
Active, closed
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
50
Barcelona, Terrassa, Burgos, Alcorcón, Madrid, Cartagena, Marbella, Seville
2016-05-18
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Alcorcón, Barcelona, Cadiz, Córdoba, Madrid, San Sebastián de los Reyes, Valencia
2014-11-26
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
A Coruña, Barcelona, Alcorcón, Vigo, Seville, Madrid, Sabadell, Valencia
1991-04-01
Rows per page Showing 1–61 of 61
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/alcorc-n

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 61 of those studies with a site in Alcorcón.

How many clinical trials are recruiting in Alcorcón?

29 of the 61 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 29 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Alcorcón), 61 studies
PhaseStudiesRecruitingShare
Phase 3371760.7%
Not applicable7311.5%
Observational7611.5%
Phase 27211.5%
Phase 1213.3%
Phase 2/3101.6%

Most active sponsors

Lead sponsors with the most studies (Alcorcón)
Lead sponsorStudiesRecruiting
AbbVie52
Universidad Rey Juan Carlos52
Hoffmann-La Roche42
AstraZeneca32
Incyte Corporation32
Janssen Research & Development, LLC30
Biogen21
Eli Lilly and Company20
Ferring Pharmaceuticals22
Inmunotek S.L.22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.